- Home
- / Master Pharm
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Master Pharm financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
ZŁ76.7 M
FY, 2021
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| PLN | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|---|
| Revenue | 74.6M | 71.2M | 61.4M | 76.7M |
| Cost of goods sold | 47.7M | 47.8M | 39.1M | 45.0M |
| Gross profit | 27.1M | 23.8M | 22.9M | 32.1M |
| Gross profit margin, % | 33.4% | 37.3% | 41.8% | |
| Operating expense total | 10.9M | 11.8M | 11.9M | 13.2M |
| Depreciation and amortization | 2.2M | 2.2M | 4.1M | 4.3M |
| EBITDA | 16.2M | 18.3M | 11.0M | 18.9M |
| EBITDA margin, % | 25.7% | 17.9% | 24.6% | |
| EBIT | 14.1M | 15.3M | 6.9M | 14.6M |
| EBIT margin, % | 21.5% | 11.2% | 19.1% | |
| Interest income | 110.0K | 142.0K | 179.0K | 45.0K |
| Interest expense | 118.0K | 206.0K | 190.0K | 169.0K |
| Pre tax profit | 13.6M | 15.4M | 535.0K | 5.1M |
| Income tax expense | 2.9M | 2.7M | 193.0K | 708.0K |
| Net Income | 10.7M | 12.6M | 342.0K | 4.3M |